Omega-3 marine triglycerides and Idiopathic pulmonary fibrosis - a phase IV clinical study of FDA data

Summary:

Idiopathic pulmonary fibrosis is reported as a side effect among people who take Omega-3 marine triglycerides (fish oil), especially for people who are female, 60+ old, have been taking the drug for 10+ years also take Fosamax, and have Osteoporosis.

The phase IV clinical study analyzes which people have Idiopathic pulmonary fibrosis when taking Omega-3 marine triglycerides. It is created by eHealthMe based on reports of 1,823 people who have side effects when taking Omega-3 marine triglycerides from the FDA, and is updated regularly.

What is Omega-3 marine triglycerides?

Omega-3 marine triglycerides has active ingredients of fish oil. eHealthMe is studying from 1,837 Omega-3 marine triglycerides users. Check the latest studies of Omega-3 marine triglycerides.

What is Idiopathic pulmonary fibrosis?

Idiopathic pulmonary fibrosis (chronic lung disease) is found to be associated with 1,189 drugs and 2,272 conditions by eHealthMe. Check the latest studies of Idiopathic pulmonary fibrosis.

On Jul, 08, 2026

1,823 people reported to have side effects when taking Omega-3 marine triglycerides.
Among them, 17 people (0.93%) have Idiopathic pulmonary fibrosis.

Could Omega-3 marine triglycerides cause Idiopathic pulmonary fibrosis?

Among these 17 people:

How long have people been on Omega-3 marine triglycerides when they have Idiopathic pulmonary fibrosis? *

What is the gender of people who have Idiopathic pulmonary fibrosis when taking Omega-3 marine triglycerides? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Idiopathic pulmonary fibrosis when taking Omega-3 marine triglycerides? *

What are other drugs people take besides Omega-3 marine triglycerides? *

Fosamax: 16 people, 94.12%
Vitamins: 14 people, 82.35%
Alendronate Sodium: 9 people, 52.94%
Flaxseed: 8 people, 47.06%
Tamoxifen Citrate: 6 people, 35.29%
Calcium Citrate: 6 people, 35.29%
Zanaflex: 1 person, 5.88%
Hydrocodone Bitartrate And Acetaminophen: 1 person, 5.88%
Bextra: 1 person, 5.88%
Celebrex: 1 person, 5.88%

What are other side effects people have besides Idiopathic pulmonary fibrosis? *

Femur Fracture: 16 people, 94.12%
High Blood Cholesterol: 13 people, 76.47%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 13 people, 76.47%
Anaemia (lack of blood): 12 people, 70.59%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 12 people, 70.59%
Depression: 12 people, 70.59%
Fall: 10 people, 58.82%
Intervertebral Disc Protrusion (spinal disc protrusion): 9 people, 52.94%
Rib Fracture: 9 people, 52.94%
Rickets (softening of bones): 9 people, 52.94%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 9 people, 52.94%
Osteopenia (a condition where bone mineral density is lower than normal): 8 people, 47.06%
Breast Cancer: 6 people, 35.29%
Type 2 Diabetes: 1 person, 5.88%
Sinus Disorder (disease of sinus): 1 person, 5.88%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 5.88%
Muscle Spasms (muscle contraction): 1 person, 5.88%
Menopause (end of monthly cycles in women): 1 person, 5.88%
Hypersensitivity: 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Omega-3 marine triglycerides and have Idiopathic pulmonary fibrosis?

- Check whether Idiopathic pulmonary fibrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omega-3 marine triglycerides:

Omega-3 marine triglycerides (1,837 reports)

Browse all side effects of Omega-3 marine triglycerides:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Idiopathic pulmonary fibrosis:

Idiopathic pulmonary fibrosis (1,189 drugs)

Browse all the conditions that are associated with Idiopathic pulmonary fibrosis:

Idiopathic pulmonary fibrosis (2,272 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fish oil (the active ingredients of Omega-3 marine triglycerides) and Omega-3 marine triglycerides (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.